Food Allergy Diagnostics & Therapeutics Market by Product Type (Diagnostic Tests Type, Therapeutic Treatment Type), Technology (Enzyme-Linked Immunosorbent Assay, Polymerase Chain Reaction), Source, Component, End-User - Global Forecast 2024-2030

Food Allergy Diagnostics & Therapeutics Market by Product Type (Diagnostic Tests Type, Therapeutic Treatment Type), Technology (Enzyme-Linked Immunosorbent Assay, Polymerase Chain Reaction), Source, Component, End-User - Global Forecast 2024-2030

The Food Allergy Diagnostics & Therapeutics Market size was estimated at USD 5.86 billion in 2023 and expected to reach USD 6.43 billion in 2024, at a CAGR 10.35% to reach USD 11.69 billion by 2030.Food allergy diagnostics & therapeutics include drugs, therapies, and diagnostics that reduce the symptoms of food allergies and help the immune system prepare for future encounters. The rising prevalence of food allergies worldwide is driving the usage of food allergy diagnostics & therapeutics. Symptoms associated with the food allergic response could range from itchiness, swelling of the tongue, or hives to low blood pressure, diarrhea, or vomiting. The common food allergens are eggs, milk, wheat, fish, and tree nuts. In addition, technological advancements and an increase in the number of R&D initiatives being undertaken to develop drugs with higher efficacy are expected to create opportunities for the growth of the food allergy diagnostics & therapeutics market. However, the high cost associated with food allergy diagnostics & treatments makes them unaffordable for people in low-income countries.Regional InsightsThe Americas represents a highly developing landscape for the food allergy diagnostics & therapeutics market characterized by the rising development of new diagnostic methods and an increasing number of people suffering from food allergies. According to Food Allergy Research & Education (FARE) data from 2021, one in ten adults and one in 13 children have different food allergies in America. Similarly, 32 million people in the United States have food allergies, and some common food allergens include milk, egg, peanut, tree nuts, wheat, soy, fish, and crustacean shellfish are common in the United States. The market innovators in the region are expanding their R&D activities to increase the development of new and advanced food allergy diagnostic tests. In August 2022, Eurofins Craft Technologies developed a new method to quantify different phenolic acids in foods and supplements. Phenolics are present in fruits, vegetables, grains, oils, and drinks such as coffee, tea, and wine. The increasing number of food testing labs in India, Australia, China, and Japan is expected to expand the scope of the food allergy diagnostic and therapeutics market in Asia-Pacific. In September 2021, SGS SA launched the Advance Center of Testing (ACT) at its Ambattur, Chennai, India laboratory premises, and the ACT provides fast and precise services to the agriculture and food industries.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Food Allergy Diagnostics & Therapeutics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Food Allergy Diagnostics & Therapeutics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Food Allergy Diagnostics & Therapeutics Market, highlighting leading vendors and their innovative profiles. These include 7 Drops Diagnostics, Inc., ACON Laboratories, Inc., AESKU.GROUP GmbH, ALK-Abelló A/S, Allergy Therapeutics PLC, Alpha Laboratories, Apexhealth by Acecgt Diagnostic Limited, Apollo Diagnostics, Aster Clinical Lab LLP, Astra Biotech GmbH, bioMérieux SA, Cerascreen GmbH, Eurofins Scientific (Ireland) Limited, EUROIMMUN Medizinische Labordiagnostika AG, HollisterStier Allergy by Jubilant Pharma Holdings Inc., HYCOR Biomedical, Indoor Biotechnologies, Inc., Laboratory Corporation of America Holdings., Lincoln Diagnostics, Inc., Medeca Pharma AB, Microbac Laboratories, Inc., Minaris Medical America, Inc., Neogen Corporatio, Nestlé Health Science, Omega Diagnostics Group PLC, Prota Therapeutics Pty. Ltd., Quest Consumer Inc., R-Biopharm AG, Romer Labs Division Holding GmbH, ROXALL Medizin GmbH, Siemens AG, STALLERGENES GREER International AG, Tecan Trading AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage



This research report categorizes the Food Allergy Diagnostics & Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product Type
Diagnostic Tests Type
In Vitro

In Vivo/Skin
Patch Test

Skin Prick Test
Therapeutic Treatment Type
Antihistamines

Epinephrine Auto-Injector
Technology
Enzyme-Linked Immunosorbent Assay
Polymerase Chain Reaction
Source
Eggs
Fish
Milk
Peanuts
Shellfish
Soy
Tree Nuts
Wheat
Component
Consumables
Instruments
Services
End-User
Academic Research Institutes
Diagnostics Laboratories
Hospitals & Clinics
Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas
Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam
Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Food Allergy Diagnostics & Therapeutics Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Food Allergy Diagnostics & Therapeutics Market?
3. What are the technology trends and regulatory frameworks in the Food Allergy Diagnostics & Therapeutics Market?
4. What is the market share of the leading vendors in the Food Allergy Diagnostics & Therapeutics Market?
5. Which modes and strategic moves are suitable for entering the Food Allergy Diagnostics & Therapeutics Market?

Note: PDF & Excel + Online Access - 1 Year